KMTS
Kestra Medical Technologies, Ltd.
25.80$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | -12.1% | +1,056.0% | +138.1% | -31.1% | +9.3% | |
| – | – | -35.1% | +23.1% | +1,531.0% | +38.6% | |
| – | – | – | +238.1% | -241.4% | – | |
| – | +44.8% | +4,501.5% | -19.1% | +88.5% | +47.9% | |
| – | +44.0% | +4,529.0% | -20.9% | +90.6% | +772.1% | |
| – | +2.2% | +258.8% | +19.1% | +107.0% | -80.5% | |
| – | – | – | – | – | – | |
| – | – | -126.7% | – | -100.0% | – | |
| – | +61.4% | +96.9% | -19.1% | +324.9% | -55.5% | |
| – | – | -40.8% | -161.2% | – | -160.1% | |
| – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.